Exclusive - GPs make glitazone switch after safety fears

GPs appear to be abandoning use of the NICE-approved drug rosiglitazone over safety fears, GP can reveal.

Figures obtained from the NHS Prescribing Pricing Division under the Freedom of Information Act show that the number of prescriptions by GPs in England for rosiglitazone fell by 36 per cent between July 2007 and June 2008.

Doubts over the type-2 diabetes drug were first raised in May last year, when US research found it was associated with a 63 per cent increased risk of death from a cardiovascular cause. Current NICE type-2 diabetes guidance continues to recommend the drug.

But the figures obtained by GP show monthly prescribing of rosiglitazone decreased from 117,214 prescriptions in July 2007 to 75,499 in June 2008.

This is in stark contrast to pioglitazone prescribing, which has increased over the same period by 44 per cent.

Between July 2007 and June 2008, monthly prescribing of pioglitazone increased from 53,091 to 76,495. It is now the most commonly prescribed glitazone in England.

Dr Mark Hadley-Brown, chairman of the Primary Care Diabetes Society (PCDS) and a Norfolk GP, said fears that rosiglitazone might increase cardiovascular risk were to blame for the slump in prescribing.

'I am not surprised by the tendency of GPs to use pioglitazone in preference to rosiglitazone.

'If in doubt, and there is genuine doubt, we're going to play safe for our patients.'

Dr Brian Karet, diabetes lead for Bradford PCT, said safety warnings on rosiglitazone packaging had prompted GPs to stop prescribing the drug.

A spokeswoman for GSK, the manufacturer of rosiglitazone (Avandia), said: 'GSK stands firmly behind the safety profile of Avandia when used according to its label, and we believe its benefits continue to outweigh any treatment risks.'

sanjay.tanday@haymarket.com

Prescribing switch:  36% - decrease in rosiglitazone prescribing
Source: NHS Prescribing Pricing Division.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs have demanded urgent action to prevent avoidable harm to patients from the NHS...

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

GP practices will be unable to cope with a second wave of COVID-19 unless urgent...

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Dr Vasu Siva explains how her practice is aiming to cut its carbon emissions by targeting...

RCGP chair warns of 'significant problem' over flu vaccine supplies

RCGP chair warns of 'significant problem' over flu vaccine supplies

The NHS faces a 'significant problem' with flu vaccine supplies as it aims to cover...

GMC overhauls consent advice to improve patient involvement in decisions about care

GMC overhauls consent advice to improve patient involvement in decisions about care

The GMC has overhauled its guidance on patient consent - setting out seven key principles...

Government must show evidence behind PPE strategy, warns BMA

Government must show evidence behind PPE strategy, warns BMA

Chronic shortages of personal protective equipment (PPE) across the NHS during the...